Venous thrombotic burden and the risk of subsequent overt cancer

• References

• 1 Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-410.
• 2 Monreal M, Lensing AWA, Prins MH. et al. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2004; 2: 876-881.
• 3 Piccioli A, Lensing AWA, Prins MH. et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism. J Thromb Hae-most 2004; 2: 884-889.
• 4 Van Doormaal FF, Terpstra W, Van Der Griend R. et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted?. J Thromb Haemost 2011; 9: 79-84.
• 5 Piccioli A, Bernardi E, Dalla Valle F. et al. The value of CT scanning for the detection of occult cancer in patients with unprovoked VTE. The D’Acquapendente study. Submitted.
• 6 Di Nisio M, Otten HM, Piccioli A. et al. Decision analysis for cancer screening in idiopathic venous thromboembolism. J Thromb Haemost 2005; 3: 2391-2396.
• 7 Bura A, Cailleux N, Bienvenu B. et al. Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2004; 2: 441-444.
• 8 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-722.
• 9 Trujillo-Santos J, Prandoni P, Rivron-Guillot K. et al. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008; 6: 251-255.
• 10 Prandoni P, Lensing AWA, Prins MH. et al. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 2015; 41: 133-140.